Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The publishing of academic research is often the long awaited culmination of significant work by the authors. During the submission process, the author has many options that need to be considered: Which journal? Which media—print or exclusively online? Should the reader or the author pay for access, or should it be published within the emerging market of open access? The act of publishing is necessary for several reasons; firstly, the process is peerreviewed, which sets a quality control bench-mark that all published research has to achieve. Secondly, the access of research to a wider audience allows novel information to be accessible, which can in turn influence further research and ultimately direct treatment options. Research that does not influence medical practice is purely an academic exercise. The gold standard of research is to direct local and national evidence-based guidelines. To facilitate this process, access to results needs to be possible at local, regional, and national levels and if possible, in real time. Furthermore, such results should be clear, concise, and focused, which permits streamline and efficient research efforts. However, further thought needs to be taken regarding factors such as intellectual property and ownership of results, of particular importance when the financial burden of research efforts is considered. Developing nations face further issues, over and above those faced by their industrialized counterparts. Such countries tend to be resource poor, which necessitates the most efficient of treatment options. More complexity is added as these countries often face different disease burdens and pathologies, patient demographics, poorer infrastructure, and significantly reduced availability of resources. Ultimately, up-to-date research can benefit all patients, in both developing and industrialized nations, and should be considered a necessary sphere of medicine.

Original publication

DOI

10.1007/978-3-319-18443-2_10

Type

Chapter

Book title

Cancer Research and Clinical Trials in Developing Countries A Practical Guide

Publication Date

01/01/2015

Pages

201 - 212